Representative Director
Haruhisa Inoue

Stem cells have the unique ability to both self-renew and differentiate into specific cell types. Among them, pluripotent stem cells including ES cells and iPS cells, as well as tissue-specific adult stem cells, have each played critical roles in advancing biology and medicine.

Originally expected to serve mainly as sources for regenerative medicine, stem cells are now widely used to create disease models, study disease mechanisms, and support drug discovery. In particular, iPS cell technology, which enables patient-derived cells to be reprogrammed and differentiated into disease-relevant cells, has been a major breakthrough in 21st-century life science and has opened new opportunities for personalized medicine.

Today, rapid progress in cell culture, organoid and MPS technologies, genome editing, and AI integration is driving stem cell research into a new era. These advances are helping us to better understand diseases, discover new treatments, and connect basic research with clinical application.

The Japan Disease Stem Cell Society (JDSCS) was founded to bring together experts from diverse fields and to provide a platform for collaboration, innovation, and communication with society. We are committed to supporting high-quality research, nurturing the next generation of scientists, and contributing to the future of medicine through disease stem cell research.

We look forward to your active participation and continued support in our shared mission.